Name
Session V: Therapeutic Approaches to Fibrosis
Date & Time
Tuesday, June 9, 2026, 3:30 PM - 5:30 PM
Scott Friedman MD Carine Boustany, PhD Mitchell Jones, MD, PhD Scott MacDonnell, PhD Thomas Wynn
Description

Chairperson: Scott MacDonnell, PhD, Regeneron

3:30 PM 

Mechanism of Action of Nerandomilast in Pulmonary Fibrosis
Carine Boustany, PhD,
 Boehringer Ingelheim 

3:55 PM 

From Mouse to Human: Translational Modeling of Intestinal Fibrosis in IBD
Scott MacDonnell, PhD,
Regeneron

4:20 PM 

Gut Restricted PED4 Inhibitor for the Treatment of Fibrostenosing Crohn’s Disease
Mitchell Jones, MD, PhD,
 Palisade Bio

4:45 PM

Closing Keynote Presentation: Fibrosis — From Mechanisms to Medicines
Thomas A Wynn, PhD,
 Pfizer